Review



sod1 g93a cat 26401 constructs  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc sod1 g93a cat 26401 constructs
    Sod1 G93a Cat 26401 Constructs, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/pF155+pcDNA3%2E1(%2B)SOD1G93A+(Plasmid+%2326401)/pm41917183-267-8-16
    Average 93 stars, based on 14 article reviews
    sod1 g93a cat 26401 constructs - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Plasmid Preparation:

    Article Title: Sonic Hedgehog-Gli1 Signaling and Cellular Retinoic Acid Binding Protein 1 Gene Regulation in Motor Neuron Differentiation and Diseases
    Article Snippet: MN1 cells were maintained with DMEM (11965, Gibco, Baltimore, MD, USA) supplemented with 10% fetal bovine serum (S11150, Atlanta, MN, USE), and 1% penicillin and streptomycin (25140, Gibco). .. ALS cell disease model: Plasmid plv-AcGFP-SOD1 WT (27138, Addgene, Cambridge, MA, USA) and G93A (27142, Addgene) were purchased from Addgene. .. MN1 cells transfection was performed by Lipofectamine 3000 (L3000015, Fisher Scientific, Waltham, MA, USA) and conducted following the manufacturer’s instruction.



    Similar Products

    94
    MedChemExpress sod1 g93a
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    Sod1 G93a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/SOD1%2C+Human/pmc13685294-381-3-15
    Average 94 stars, based on 1 article reviews
    sod1 g93a - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory g93a mutation
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    G93a Mutation, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mutation/pm42275159-239-16-22
    Average 86 stars, based on 1 article reviews
    g93a mutation - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory g93a substitution
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    G93a Substitution, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+substitution/pm42240799-43-8-29
    Average 86 stars, based on 1 article reviews
    g93a substitution - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory b6sjl tg sod1 g93a 1gur j
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    B6sjl Tg Sod1 G93a 1gur J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mice+sod1/pmc13198251-27-0-2
    Average 86 stars, based on 1 article reviews
    b6sjl tg sod1 g93a 1gur j - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory b6 sod1 g93a
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    B6 Sod1 G93a, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mice+sod1/bio_rxiv__64898__2026__05__04__722437-204-8-37
    Average 86 stars, based on 1 article reviews
    b6 sod1 g93a - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory b6sjl sod1 g93a
    Dynamic changes in microglial state during disease progression in <t>SOD1</t> <t>G93A</t> mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant
    B6sjl Sod1 G93a, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mice+sod1/bio_rxiv__64898__2026__05__04__722437-204-12-37
    Average 86 stars, based on 1 article reviews
    b6sjl sod1 g93a - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory sod1 g93a mice
    Transcriptomic analysis revealed deregulated genes and pathways in spinal cord and skeletal muscle <t>of</t> <t>SOD1-G93A</t> mice. ( a , b ) Volcano plot of differential gene expression in SOD1-G93A mice versus control mice using the Wald test for spinal cord (SC) and gastrocnemius (GNM) tissues. The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively. ( c , d ) Heatmap of differentially expressed genes in spinal cord and gastrocnemius, respectively, between SOD1-G93A and control mice. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( e , f ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score. ( g ) Venn diagram showing the number of differentially expressed genes (DEGs) in GNM and SC. Common DEGs are indicated in the intersection. ( h ) Comparative dotplot of common deregulated pathways between tissues.
    Sod1 G93a Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mice+sod1/pmc13113488-42-0-7
    Average 86 stars, based on 1 article reviews
    sod1 g93a mice - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Addgene inc sod1 g93a cat 26401 constructs
    Transcriptomic analysis revealed deregulated genes and pathways in spinal cord and skeletal muscle <t>of</t> <t>SOD1-G93A</t> mice. ( a , b ) Volcano plot of differential gene expression in SOD1-G93A mice versus control mice using the Wald test for spinal cord (SC) and gastrocnemius (GNM) tissues. The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively. ( c , d ) Heatmap of differentially expressed genes in spinal cord and gastrocnemius, respectively, between SOD1-G93A and control mice. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( e , f ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score. ( g ) Venn diagram showing the number of differentially expressed genes (DEGs) in GNM and SC. Common DEGs are indicated in the intersection. ( h ) Comparative dotplot of common deregulated pathways between tissues.
    Sod1 G93a Cat 26401 Constructs, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/pF155+pcDNA3%2E1(%2B)SOD1G93A+(Plasmid+%2326401)/pm41917183-267-8-16
    Average 93 stars, based on 1 article reviews
    sod1 g93a cat 26401 constructs - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    86
    Jackson Laboratory transgenic hsod1 g93a als mice
    Transcriptomic analysis revealed deregulated genes and pathways in spinal cord and skeletal muscle <t>of</t> <t>SOD1-G93A</t> mice. ( a , b ) Volcano plot of differential gene expression in SOD1-G93A mice versus control mice using the Wald test for spinal cord (SC) and gastrocnemius (GNM) tissues. The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively. ( c , d ) Heatmap of differentially expressed genes in spinal cord and gastrocnemius, respectively, between SOD1-G93A and control mice. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( e , f ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score. ( g ) Venn diagram showing the number of differentially expressed genes (DEGs) in GNM and SC. Common DEGs are indicated in the intersection. ( h ) Comparative dotplot of common deregulated pathways between tissues.
    Transgenic Hsod1 G93a Als Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/g93a/g93a+mice+sod1/pm41846014-35-0-11
    Average 86 stars, based on 1 article reviews
    transgenic hsod1 g93a als mice - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    Dynamic changes in microglial state during disease progression in SOD1 G93A mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: Dynamic changes in microglial state during disease progression in SOD1 G93A mice. a - b Representative immunofluorescent micrographs ( a ) and quantification ( b ) of ChAT-positive motor neurons in WT and SOD1 G93A mice at different ages. Motor neurons were labeled with ChAT. n = 4 mice per condition. c Heat map showing the relative mRNA expression levels of HOM and MGnD markers. Darker colors indicate higher fold changes. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the WT group. n = 4 mice per condition. d Representative immunofluorescent micrographs and 3D reconstructions of IBA1 and CD68 staining in WT and SOD1 G93A mice at different ages. e – h Quantification derived from panel ( d ), including microglial volume measured by IBA1 staining ( e ), endpoints ( f ) and maximum process length ( g ) determined by Sholl analysis, and CD68-positive volume within IBA1-positive microglia ( h ). CD68 was used as a lysosomal marker. In ( e - h ), n = 4 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Biomarker Discovery, Labeling, Expressing, Staining, Derivative Assay, Analysis, Marker

    Microglial phagocytic ability declined during the symptomatic stages of SOD1 G93A mice. a Representative micrographs and 3D reconstructions showing microglial phagocytic processing of myelin debris, assessed by IBA1, CD68, and MBP staining in WT and SOD1 G93A mice at different ages. Scale bars: 10 μm in representative micrographs and 5 μm in 3D reconstructions. b Quantification of MBP volume within CD68-positive compartments of IBA1-positive microglia in WT and SOD1 G93A mice at different ages. Phagocytic processing was quantified by normalizing the volume of MBP within CD68-positive structures to the total volume of IBA1-positive microglia. n = 4 mice per condition. c Representative immunoblots and quantification of MBP and β-ACTIN in spinal cord tissue. Protein expression levels are shown relative to the age-matched WT group. n = 7 mice per condition. d Representative micrographs and 3D reconstructions of IBA1 and NeuN staining in WT and SOD1 G93A mice at different ages. Scale bar = 10 μm. e Quantification of NeuN volume within IBA1-positive microglia. n = 4 mice per condition. f Unsupervised clustering of cell populations from the published single-cell RNA-seq dataset. g Subclustering of microglia isolated from WT and SOD1 G93A mice. Cells are colored according to their microglial subcluster identity. h Relative abundance of microglial subclusters under different conditions: SOD1 G93A -P60 (left), SOD1 G93A -P90 (right). i Gene set enrichment analysis (GSEA) scores of the indicated pathways in MG clusters. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: Microglial phagocytic ability declined during the symptomatic stages of SOD1 G93A mice. a Representative micrographs and 3D reconstructions showing microglial phagocytic processing of myelin debris, assessed by IBA1, CD68, and MBP staining in WT and SOD1 G93A mice at different ages. Scale bars: 10 μm in representative micrographs and 5 μm in 3D reconstructions. b Quantification of MBP volume within CD68-positive compartments of IBA1-positive microglia in WT and SOD1 G93A mice at different ages. Phagocytic processing was quantified by normalizing the volume of MBP within CD68-positive structures to the total volume of IBA1-positive microglia. n = 4 mice per condition. c Representative immunoblots and quantification of MBP and β-ACTIN in spinal cord tissue. Protein expression levels are shown relative to the age-matched WT group. n = 7 mice per condition. d Representative micrographs and 3D reconstructions of IBA1 and NeuN staining in WT and SOD1 G93A mice at different ages. Scale bar = 10 μm. e Quantification of NeuN volume within IBA1-positive microglia. n = 4 mice per condition. f Unsupervised clustering of cell populations from the published single-cell RNA-seq dataset. g Subclustering of microglia isolated from WT and SOD1 G93A mice. Cells are colored according to their microglial subcluster identity. h Relative abundance of microglial subclusters under different conditions: SOD1 G93A -P60 (left), SOD1 G93A -P90 (right). i Gene set enrichment analysis (GSEA) scores of the indicated pathways in MG clusters. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Staining, Western Blot, Tissue, Expressing, Single Cell, RNA Sequencing, Isolation, Analysis

    SGK1 expression was upregulated in spinal cord microglia during the symptomatic stages of SOD1 G93A mice. a Volcano plot of differentially expressed genes (DEGs) in microglia from SOD1 G93A and WT mice at the early stage of disease progression. Thresholds: fold change > 1.5 and FDR < 0.05. Blue dots indicate downregulated genes, red dots indicate upregulated genes, and grey dots indicate genes without significant differential expression. b Representative immunoblots of SGK1 and β-ACTIN in spinal cord tissue. c Quantification of SGK1 protein expression levels normalized to β-ACTIN. Expression levels are shown relative to the age-matched WT group. n = 7 mice per condition. d Representative immunofluorescent micrographs of SGK1 and IBA1 staining of WT and SOD1 G93A mice at different time points. e Pearson’s correlation coefficient between SGK1 and IBA1. n = 3 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: SGK1 expression was upregulated in spinal cord microglia during the symptomatic stages of SOD1 G93A mice. a Volcano plot of differentially expressed genes (DEGs) in microglia from SOD1 G93A and WT mice at the early stage of disease progression. Thresholds: fold change > 1.5 and FDR < 0.05. Blue dots indicate downregulated genes, red dots indicate upregulated genes, and grey dots indicate genes without significant differential expression. b Representative immunoblots of SGK1 and β-ACTIN in spinal cord tissue. c Quantification of SGK1 protein expression levels normalized to β-ACTIN. Expression levels are shown relative to the age-matched WT group. n = 7 mice per condition. d Representative immunofluorescent micrographs of SGK1 and IBA1 staining of WT and SOD1 G93A mice at different time points. e Pearson’s correlation coefficient between SGK1 and IBA1. n = 3 mice per condition. Scale bar = 10 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Expressing, Biomarker Discovery, Quantitative Proteomics, Western Blot, Tissue, Staining

    Sgk1 knockout ameliorated impaired phagocytosis in SOD1 G93A microglia. a An experimental schematic showing the generation of SOD1 G93A ; SGK1 KO mice by crossing SOD1 G93A and SGK1 KO lines. b Representative immunoblots and quantification of SGK1 and β-ACTIN in WT mice and SGK1 KO mice. n = 4 mice for the WT group and n = 3 mice for the SGK1 KO group. c Relative mRNA expression of Sgk1 in WT and SGK1 KO mice measured by qRT-PCR. n = 5 mice for the WT group and n = 4 mice for the SGK1 KO group. d Representative micrographs and Sholl analysis of IBA1-labeled microglia in SOD1 G93A mice and SOD1 G93A ; SGK1 KO mice at P120. Sholl curves were generated from 30 microglia sampled from 4 mice per condition to illustrate the distribution of microglial morphological complexity. Quantification of endpoints and process length was performed at the animal level after averaging analyzed cells within each mouse, with each data point representing one mouse. n = 4 mice per condition for endpoint and process length quantification. e Representative micrographs and 3D reconstructions showing microglial phagocytic processing of myelin debris, assessed by IBA1, CD68, and MBP staining in WT, SOD1 G93A , SGK1 KO , and SOD1 G93A ; SGK1 KO mice at P120. f Representative micrographs and 3D reconstructions showing microglial engulfment of neuronal material, assessed by IBA1 and NeuN staining. g Representative micrographs and 3D reconstructions showing lysosomal damage in microglia, assessed by IBA1, CD68, and GAL-3 staining. h - j Quantification of microglial volume ( h ), lysosomal content ( i ), and MBP volume within microglia ( j ) from panel ( e ). k Quantification of neuronal material within microglia from panel ( f ). l Quantification of GAL-3 volume within CD68-positive compartments from panel ( g ). m Quantification of motor neuron number from the corresponding ChAT staining. In ( h - m ), n = 4 mice per condition, and each data point represents the mean value from one mouse after averaging technical measurements from multiple cells or fields of view. Data are presented as mean ± SEM. Scale bar = 10 μm. * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: Sgk1 knockout ameliorated impaired phagocytosis in SOD1 G93A microglia. a An experimental schematic showing the generation of SOD1 G93A ; SGK1 KO mice by crossing SOD1 G93A and SGK1 KO lines. b Representative immunoblots and quantification of SGK1 and β-ACTIN in WT mice and SGK1 KO mice. n = 4 mice for the WT group and n = 3 mice for the SGK1 KO group. c Relative mRNA expression of Sgk1 in WT and SGK1 KO mice measured by qRT-PCR. n = 5 mice for the WT group and n = 4 mice for the SGK1 KO group. d Representative micrographs and Sholl analysis of IBA1-labeled microglia in SOD1 G93A mice and SOD1 G93A ; SGK1 KO mice at P120. Sholl curves were generated from 30 microglia sampled from 4 mice per condition to illustrate the distribution of microglial morphological complexity. Quantification of endpoints and process length was performed at the animal level after averaging analyzed cells within each mouse, with each data point representing one mouse. n = 4 mice per condition for endpoint and process length quantification. e Representative micrographs and 3D reconstructions showing microglial phagocytic processing of myelin debris, assessed by IBA1, CD68, and MBP staining in WT, SOD1 G93A , SGK1 KO , and SOD1 G93A ; SGK1 KO mice at P120. f Representative micrographs and 3D reconstructions showing microglial engulfment of neuronal material, assessed by IBA1 and NeuN staining. g Representative micrographs and 3D reconstructions showing lysosomal damage in microglia, assessed by IBA1, CD68, and GAL-3 staining. h - j Quantification of microglial volume ( h ), lysosomal content ( i ), and MBP volume within microglia ( j ) from panel ( e ). k Quantification of neuronal material within microglia from panel ( f ). l Quantification of GAL-3 volume within CD68-positive compartments from panel ( g ). m Quantification of motor neuron number from the corresponding ChAT staining. In ( h - m ), n = 4 mice per condition, and each data point represents the mean value from one mouse after averaging technical measurements from multiple cells or fields of view. Data are presented as mean ± SEM. Scale bar = 10 μm. * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Knock-Out, Western Blot, Expressing, Quantitative RT-PCR, Analysis, Labeling, Generated, Staining

    SOD1 G93A microglia exhibited increased lipid droplet accumulation and MGnD-associated changes. a Experimental schematic showing the evaluation of the effects of myelin debris and apoptotic neurons on BV2 microglia. Created with BioRender.com. b Representative micrographs showing the phagocytic activity of BV2 cells following 3 h incubation with CFSE-labeled myelin debris alone, Red CMTPX-labeled apoptotic N2a cells alone, or a combination of both. c – d Quantification of BV2 microglial phagocytosis under the indicated treatment conditions. c Phagocytosis of myelin debris. d Phagocytosis of apoptotic N2a cells. e Representative micrographs showing lipid droplets in BV2 cells treated with myelin debris alone, apoptotic N2a cells alone, or a combination of both. f Representative micrographs showing lipid droplets in BV2 cells following co-treatment with myelin debris and apoptotic N2a cells and subsequent EBSS treatment. g Representative micrographs showing the phagocytic activity of BV2 cells following 3 h incubation with CFSE-labeled myelin debris and Red CMTPX-labeled apoptotic N2a cells after EBSS treatment. h Percentage of BODIPY-positive cells following treatment with myelin debris alone, apoptotic N2a cells alone, or their combination (quantified from panel e). i Percentage of BODIPY-positive cells in BV2 cells following co-treatment with myelin debris and apoptotic N2a cells and subsequent EBSS treatment (quantified from panel f). j Quantification of phagocytosis of myelin debris and apoptotic N2a cells by BV2 cells after EBSS treatment. k Relative mRNA levels of Apoe , Itgax , Spp1 , and Clec7a in BV2 cells measured by qRT-PCR. For the quantitative cell-based imaging assays in panels ( c ), ( d ), and ( h – j ), 3 independent biological replicates were analyzed for panels ( c ), ( d ), ( h ), and ( i ), and 4 independent biological replicates were analyzed for panel ( j ). For each replicate, 3–5 fields of view (FOVs) were analyzed per condition, and the averaged value was used as a single data point for statistical analysis. Each dot represents one independent biological replicate. For qRT-PCR analysis in panel (k), n = 3 independent experiments. Scale bar = 40 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: SOD1 G93A microglia exhibited increased lipid droplet accumulation and MGnD-associated changes. a Experimental schematic showing the evaluation of the effects of myelin debris and apoptotic neurons on BV2 microglia. Created with BioRender.com. b Representative micrographs showing the phagocytic activity of BV2 cells following 3 h incubation with CFSE-labeled myelin debris alone, Red CMTPX-labeled apoptotic N2a cells alone, or a combination of both. c – d Quantification of BV2 microglial phagocytosis under the indicated treatment conditions. c Phagocytosis of myelin debris. d Phagocytosis of apoptotic N2a cells. e Representative micrographs showing lipid droplets in BV2 cells treated with myelin debris alone, apoptotic N2a cells alone, or a combination of both. f Representative micrographs showing lipid droplets in BV2 cells following co-treatment with myelin debris and apoptotic N2a cells and subsequent EBSS treatment. g Representative micrographs showing the phagocytic activity of BV2 cells following 3 h incubation with CFSE-labeled myelin debris and Red CMTPX-labeled apoptotic N2a cells after EBSS treatment. h Percentage of BODIPY-positive cells following treatment with myelin debris alone, apoptotic N2a cells alone, or their combination (quantified from panel e). i Percentage of BODIPY-positive cells in BV2 cells following co-treatment with myelin debris and apoptotic N2a cells and subsequent EBSS treatment (quantified from panel f). j Quantification of phagocytosis of myelin debris and apoptotic N2a cells by BV2 cells after EBSS treatment. k Relative mRNA levels of Apoe , Itgax , Spp1 , and Clec7a in BV2 cells measured by qRT-PCR. For the quantitative cell-based imaging assays in panels ( c ), ( d ), and ( h – j ), 3 independent biological replicates were analyzed for panels ( c ), ( d ), ( h ), and ( i ), and 4 independent biological replicates were analyzed for panel ( j ). For each replicate, 3–5 fields of view (FOVs) were analyzed per condition, and the averaged value was used as a single data point for statistical analysis. Each dot represents one independent biological replicate. For qRT-PCR analysis in panel (k), n = 3 independent experiments. Scale bar = 40 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Activity Assay, Incubation, Labeling, Quantitative RT-PCR, Imaging, Analysis

    SGK1 promoted lipid accumulation and phagocytic dysfunction in SOD1 G93A microglia. a Representative immunoblots and quantification of SGK1 and β-ACTIN in BV2 cells treated with myelin debris alone, apoptotic N2a cells alone, or a combination of both. Expression levels were normalized to β-ACTIN and are shown relative to the WT group. n = 3 independent experiments. b Representative micrographs showing phagocytosis of myelin debris and apoptotic N2a cells by WT-BV2 and G93A-BV2 cells with or without GSK650394 treatment. c Quantification of phagocytosis of myelin debris and apoptotic N2a cells by BV2 cells after GSK650394 treatment. Phagocytic activity was quantified as the engulfed signal normalized to total IBA1 fluorescence intensity to account for potential variations in cell density. n = 3 independent experiments. d Representative micrographs showing BODIPY staining of lipid droplets in BV2 cells treated with myelin debris and apoptotic N2a cells in the presence or absence of GSK650394 treatment. e Quantification of the percentage of BODIPY-positive cells from panel ( d ). Lipid accumulation was quantified as the percentage of BODIPY-positive cells. n = 3 independent experiments. f Relative mRNA expression levels of Apoe, Clec7a, Itgax, and Spp1 in BV2 cells measured by qRT-PCR. n = 3 independent experiments per group. g Representative micrographs showing TFEB and Hoechst staining in BV2 cells. h Quantification of TFEB nuclear localization. n = 4 independent experiments. i - j Representative immunoblots ( i ) and quantification ( j ) of lipophagy- and lysosome-related proteins in BV2 cells treated with myelin debris and apoptotic N2a cells in the presence or absence of GSK650394 treatment. β-ACTIN was used as the internal reference. Expression levels are shown relative to the WT group. n = 3–4 independent experiments per group. For cell-based imaging assays in ( b – h ), experiments were performed with 3–4 independent biological replicates. For each replicate, 3–5 fields of view (FOVs) were analyzed per condition, and the averaged value from these FOVs was used as a single data point for statistical analysis. Thus, each dot represents one independent biological replicate. Scale bar = 40 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Journal: Journal of Neuroinflammation

    Article Title: SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis

    doi: 10.1186/s12974-026-03925-w

    Figure Lengend Snippet: SGK1 promoted lipid accumulation and phagocytic dysfunction in SOD1 G93A microglia. a Representative immunoblots and quantification of SGK1 and β-ACTIN in BV2 cells treated with myelin debris alone, apoptotic N2a cells alone, or a combination of both. Expression levels were normalized to β-ACTIN and are shown relative to the WT group. n = 3 independent experiments. b Representative micrographs showing phagocytosis of myelin debris and apoptotic N2a cells by WT-BV2 and G93A-BV2 cells with or without GSK650394 treatment. c Quantification of phagocytosis of myelin debris and apoptotic N2a cells by BV2 cells after GSK650394 treatment. Phagocytic activity was quantified as the engulfed signal normalized to total IBA1 fluorescence intensity to account for potential variations in cell density. n = 3 independent experiments. d Representative micrographs showing BODIPY staining of lipid droplets in BV2 cells treated with myelin debris and apoptotic N2a cells in the presence or absence of GSK650394 treatment. e Quantification of the percentage of BODIPY-positive cells from panel ( d ). Lipid accumulation was quantified as the percentage of BODIPY-positive cells. n = 3 independent experiments. f Relative mRNA expression levels of Apoe, Clec7a, Itgax, and Spp1 in BV2 cells measured by qRT-PCR. n = 3 independent experiments per group. g Representative micrographs showing TFEB and Hoechst staining in BV2 cells. h Quantification of TFEB nuclear localization. n = 4 independent experiments. i - j Representative immunoblots ( i ) and quantification ( j ) of lipophagy- and lysosome-related proteins in BV2 cells treated with myelin debris and apoptotic N2a cells in the presence or absence of GSK650394 treatment. β-ACTIN was used as the internal reference. Expression levels are shown relative to the WT group. n = 3–4 independent experiments per group. For cell-based imaging assays in ( b – h ), experiments were performed with 3–4 independent biological replicates. For each replicate, 3–5 fields of view (FOVs) were analyzed per condition, and the averaged value from these FOVs was used as a single data point for statistical analysis. Thus, each dot represents one independent biological replicate. Scale bar = 40 μm. Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns : not significant

    Article Snippet: For SGK1 inhibition, SOD1 G93A and WT mice were intraperitoneally injected with 1 mg/kg GSK650394 (MedChemExpress, USA) every three days, starting from postnatal day 60 (P60) until the disease endpoint.

    Techniques: Western Blot, Expressing, Activity Assay, Fluorescence, Staining, Quantitative RT-PCR, Imaging, Analysis

    Transcriptomic analysis revealed deregulated genes and pathways in spinal cord and skeletal muscle of SOD1-G93A mice. ( a , b ) Volcano plot of differential gene expression in SOD1-G93A mice versus control mice using the Wald test for spinal cord (SC) and gastrocnemius (GNM) tissues. The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively. ( c , d ) Heatmap of differentially expressed genes in spinal cord and gastrocnemius, respectively, between SOD1-G93A and control mice. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( e , f ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score. ( g ) Venn diagram showing the number of differentially expressed genes (DEGs) in GNM and SC. Common DEGs are indicated in the intersection. ( h ) Comparative dotplot of common deregulated pathways between tissues.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Transcriptomic analysis revealed deregulated genes and pathways in spinal cord and skeletal muscle of SOD1-G93A mice. ( a , b ) Volcano plot of differential gene expression in SOD1-G93A mice versus control mice using the Wald test for spinal cord (SC) and gastrocnemius (GNM) tissues. The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively. ( c , d ) Heatmap of differentially expressed genes in spinal cord and gastrocnemius, respectively, between SOD1-G93A and control mice. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( e , f ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score. ( g ) Venn diagram showing the number of differentially expressed genes (DEGs) in GNM and SC. Common DEGs are indicated in the intersection. ( h ) Comparative dotplot of common deregulated pathways between tissues.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Gene Expression, Control, Transformation Assay, Derivative Assay

    Validation of RNA-seq analysis in spinal cord and gastrocnemius of SOD1-G93A mice. ( a , b ) RT-qPCR on two deregulated genes from spinal cord (SC) and gastrocnemius (GNM) RNA-seq analysis. Data are represented as mean ± SEM with 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using Gapdh and beta-2-microglobulin (B2m) as housekeeping genes for SC and GNM respectively. Unpaired t -tests were used; * p < 0.05, ** p < 0.01, *** p < 0.001. ( c , d ) Spearman’s correlation test between 2 −ΔCt values and DESeq2 counts from RT-qPCR and RNA-seq analysis, respectively. p -value and Spearman’s r coefficient are displayed in the graphs.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Validation of RNA-seq analysis in spinal cord and gastrocnemius of SOD1-G93A mice. ( a , b ) RT-qPCR on two deregulated genes from spinal cord (SC) and gastrocnemius (GNM) RNA-seq analysis. Data are represented as mean ± SEM with 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using Gapdh and beta-2-microglobulin (B2m) as housekeeping genes for SC and GNM respectively. Unpaired t -tests were used; * p < 0.05, ** p < 0.01, *** p < 0.001. ( c , d ) Spearman’s correlation test between 2 −ΔCt values and DESeq2 counts from RT-qPCR and RNA-seq analysis, respectively. p -value and Spearman’s r coefficient are displayed in the graphs.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Biomarker Discovery, RNA Sequencing, Quantitative RT-PCR

    Transcriptomic analysis of spinal cord and skeletal muscle of SOD1-G93A and SOD1-G93A treated with SPD. ( a , b ) Volcano plot of differentially expressed genes from spinal cord (SC) and gastrocnemius (GNM) tissues of SOD1-G93A and SOD1-G93A mice treated with SPD (SOD1-G93A SPD). The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively, while grey points represent not significant genes. ( c ) Heatmap of the 10 genes whose expression is reverted in the WT vs. ALS and ALS vs. ALS + SPD comparisons for SC. ( d , e ) Venn diagram and heatmap of 3590 common genes between WT vs. ALS and ALS vs. ALS + SPD for GNM. In Venn diagram are represented DEGs in a red circle for ALS vs. CTR comparison, while in a blue circle for ALS SPD vs. ALS comparison. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene (DEG) across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( f , g ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue respectively. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Transcriptomic analysis of spinal cord and skeletal muscle of SOD1-G93A and SOD1-G93A treated with SPD. ( a , b ) Volcano plot of differentially expressed genes from spinal cord (SC) and gastrocnemius (GNM) tissues of SOD1-G93A and SOD1-G93A mice treated with SPD (SOD1-G93A SPD). The statistically significant up-regulated and down-regulated genes are shown in red and blue respectively, while grey points represent not significant genes. ( c ) Heatmap of the 10 genes whose expression is reverted in the WT vs. ALS and ALS vs. ALS + SPD comparisons for SC. ( d , e ) Venn diagram and heatmap of 3590 common genes between WT vs. ALS and ALS vs. ALS + SPD for GNM. In Venn diagram are represented DEGs in a red circle for ALS vs. CTR comparison, while in a blue circle for ALS SPD vs. ALS comparison. Each row of the heatmap represents the z-score-transformed DESeq2 values of one differentially expressed gene (DEG) across all samples. The row z-score is represented by a color code (blue, down-regulated genes; red, up-regulated genes). ( f , g ) Dotplot of significant pathways derived from gene set enrichment analysis (GSEA) for SC and GNM tissue respectively. The colors represent the p -value adjusted by Benjamini–Hochberg correction. The dot dimension represents the number of DEGs for that pathway. NES, normalized enrichment score.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Expressing, Comparison, Transformation Assay, Derivative Assay

    Validation of some DEGs in spinal cord tissue of SOD1-G93A mice after SPD treatment. ( a – d ) RT-qPCR of deregulated genes from RNA-seq analysis for spinal cord. Data are represented as mean ± SEM using expression levels measured using 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using Gapdh as housekeeping gene. One-way ANOVA, followed by Tukey’s post hoc test, was used; * p < 0.05, ** p < 0.01, *** p < 0.001. ( e – h ) Spearman’s correlation test was used to assess a correlation between 2 −ΔCt values and DESeq2 counts from RNA-seq analysis. p -value and Spearman’s r coefficient are displayed in the graphs.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Validation of some DEGs in spinal cord tissue of SOD1-G93A mice after SPD treatment. ( a – d ) RT-qPCR of deregulated genes from RNA-seq analysis for spinal cord. Data are represented as mean ± SEM using expression levels measured using 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using Gapdh as housekeeping gene. One-way ANOVA, followed by Tukey’s post hoc test, was used; * p < 0.05, ** p < 0.01, *** p < 0.001. ( e – h ) Spearman’s correlation test was used to assess a correlation between 2 −ΔCt values and DESeq2 counts from RNA-seq analysis. p -value and Spearman’s r coefficient are displayed in the graphs.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Biomarker Discovery, Quantitative RT-PCR, RNA Sequencing, Expressing

    Validation of genes related to mitochondrial and ribosomal protein pathways emerging from GSEA in gastrocnemius tissue of SOD1-G93A mice after SPD treatment. ( a – c , g – i ) RT-qPCR of deregulated genes from RNA-seq analysis of gastrocnemius. Data are mean ± SEM represented using expression levels measured using 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using beta-2-microglobulin (B2m) as housekeeping gene. One-way ANOVA, followed by Tukey’s post hoc test, was used; * p < 0.05, ** p < 0.01. ( d – f , j – l ) Spearman’s correlation test was used to assess a correlation between 2 −ΔCt values and DESeq2 counts from RNA-seq analysis, n = 3 mice per experimental group. p -value and Spearman’s r coefficient are displayed in the graphs.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Validation of genes related to mitochondrial and ribosomal protein pathways emerging from GSEA in gastrocnemius tissue of SOD1-G93A mice after SPD treatment. ( a – c , g – i ) RT-qPCR of deregulated genes from RNA-seq analysis of gastrocnemius. Data are mean ± SEM represented using expression levels measured using 2 −ΔΔCt method for n = 3 mice per experimental group. Data were normalized using beta-2-microglobulin (B2m) as housekeeping gene. One-way ANOVA, followed by Tukey’s post hoc test, was used; * p < 0.05, ** p < 0.01. ( d – f , j – l ) Spearman’s correlation test was used to assess a correlation between 2 −ΔCt values and DESeq2 counts from RNA-seq analysis, n = 3 mice per experimental group. p -value and Spearman’s r coefficient are displayed in the graphs.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Biomarker Discovery, Quantitative RT-PCR, RNA Sequencing, Expressing

    Spermidine has a positive effect on mitochondrial bioenergetics in C2C12 cells expressing hSOD1-G93A mutation ( a ) and in NSC34 expressing hTDP43 Q331K mutation ( b ). Individual parameters for basal respiration, maximal respiration, ATP production and spare respiratory capacity were measured. Data are shown as mean ± SEM. One-way ANOVA, with Tukey’s post hoc test, was used. Values significantly different from control (WT) are indicated with # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001. Values significantly different from ALS condition (SOD1 G93A and TDP43 331) are represented with * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Spermidine has a positive effect on mitochondrial bioenergetics in C2C12 cells expressing hSOD1-G93A mutation ( a ) and in NSC34 expressing hTDP43 Q331K mutation ( b ). Individual parameters for basal respiration, maximal respiration, ATP production and spare respiratory capacity were measured. Data are shown as mean ± SEM. One-way ANOVA, with Tukey’s post hoc test, was used. Values significantly different from control (WT) are indicated with # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001. Values significantly different from ALS condition (SOD1 G93A and TDP43 331) are represented with * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Expressing, Mutagenesis, Control

    Body weight and grip strength analyses of SOD1-G93A mice treated with SPD. ( a ) Graph representing the weight of WT, SOD1-G93A and SOD1-G93A + SPD mice at the indicated ages. Data are presented as the means ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 for ALS vs. WT comparison. ( b ) Maximal grip strength for WT, SOD1-G93A and SOD1-G93A + SPD mice. Data are presented as the means ± SEM; ** p < 0.01, *** p < 0.001 and **** p < 0.0001 for ALS vs. WT comparison; # p < 0.05 for ALS vs. ALS + SPD comparison; § p < 0.05 and §§ p < 0.01 for ALS SPD vs. WT comparison. Two-way ANOVA Multiple comparisons test was used.

    Journal: Biomolecules

    Article Title: Transcriptomic Analysis Reveals the Beneficial Effects of Spermidine in an ALS Mouse Model

    doi: 10.3390/biom16040566

    Figure Lengend Snippet: Body weight and grip strength analyses of SOD1-G93A mice treated with SPD. ( a ) Graph representing the weight of WT, SOD1-G93A and SOD1-G93A + SPD mice at the indicated ages. Data are presented as the means ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 for ALS vs. WT comparison. ( b ) Maximal grip strength for WT, SOD1-G93A and SOD1-G93A + SPD mice. Data are presented as the means ± SEM; ** p < 0.01, *** p < 0.001 and **** p < 0.0001 for ALS vs. WT comparison; # p < 0.05 for ALS vs. ALS + SPD comparison; § p < 0.05 and §§ p < 0.01 for ALS SPD vs. WT comparison. Two-way ANOVA Multiple comparisons test was used.

    Article Snippet: SOD1-G93A mice (B6.Cg-Tg(SOD1 G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).

    Techniques: Comparison